Quantcast

Latest urge incontinence Stories

2009-09-03 05:30:00

MINNEAPOLIS, Sept. 3 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted results published in the September, 2009 edition of THE JOURNAL OF UROLOGY(R) from the OrBIT trial of its Urgent PC System. The Urgent PC System is a proprietary, minimally invasive percutaneous tibial nerve stimulation (PTNS) device designed for office-based treatment of...

2009-07-13 05:30:00

MINNEAPOLIS, July 13 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,536,226 entitled, "Electro-Nerve Stimulator System and Methods." The patent covers the company's Urgent(R) PC system and stimulation methods for treatment of the overactive bladder ("OAB") symptoms of urinary urgency,...

2009-01-26 05:30:00

Study to support Urgent(R) PC clinical success and expanded reimbursement coverage MINNEAPOLIS, Jan. 26 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI) announced today the completion of patient enrollment in the randomized, controlled multicenter clinical study of its Urgent PC neuromodulation system for the treatment of overactive bladder (OAB) symptoms of urinary urgency, urge incontinence and frequency of urinary voids. A total of 214 patients have enrolled two months ahead of...

2008-10-02 18:00:30

MINNEAPOLIS, Oct. 2 /PRNewswire-FirstCall/ -- Uroplasty, Inc. announced today the enrollment of the first patients in a new randomized, controlled multicenter clinical study of its FDA cleared Urgent PC neuromodulation system for the treatment of overactive bladder (OAB) symptoms of urinary urgency, urge incontinence and frequency of urinary voids. The study is designed to directly compare the effectiveness of Urgent PC treatment to non-active treatment. Uroplasty is undertaking this...

2008-07-21 12:01:26

MINNEAPOLIS, July 21 /PRNewswire-FirstCall/ -- Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunction, today announced that it has become a member of the National Association For Continence's (NAFC) Industry Council. "Uroplasty looks forward to contributing in a meaningful way to the important public programming and advocacy that NAFC brings to the very large community impacted by...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related